SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* SMITH BRIAN TRAVIS (Last) (First) (Middle) 200 S. WILCOX DRIVE (Street) KINGSPORT TN 37660 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/10/2022	3. Issuer Name and Ticker or Trading Symbol EASTMAN CHEMICAL CO [ EMN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, Add & Funct Prod	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7	I	401(k)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/25/2023(1)	02/24/2032	Common Stock	5,178	$120.8	D
Employee Stock Option (right to buy)	02/26/2022(2)	02/25/2031	Common Stock	5,608	$109.26	D
Employee Stock Option (right to buy)	02/28/2022(3)	02/27/2030	Common Stock	4,794	$61.51	D
Employee Stock Option (right to buy)	10/15/2020(4)	10/15/2029	Common Stock	10,289	$72.92	D
Employee Stock Option (right to buy)	02/28/2022	02/27/2029	Common Stock	2,862	$82.69	D
Employee Stock Option (right to buy)	02/26/2019	02/25/2028	Common Stock	7,520	$104.21	D
Employee Stock Option (right to buy)	02/28/2015	02/27/2024	Common Stock	2,639	$87.43	D
Restricted Stock Units	12/01/2023(5)	12/01/2023(5)	Common Stock	10,124	(5)	D
Restricted Stock Units	10/15/2022(5)	10/15/2022(5)	Common Stock	1,715	(5)	D

Explanation of Responses:

1. One-third of option becomes exercisable on each of February 25, 2023, February 25, 2024, and February 25, 2025.

2. One-third of option became exercisable on February 26, 2022 and one-third of option becomes exercisable on each of February 26, 2023, and February 26, 2024.

3. One-half of option became exercisable on February 28, 2022 and one-half of option becomes exercisable on February 28, 2023.

4. One-third of option became exercisable on each of October 15, 2020, October 15, 2021 one-third of option becomes exercisable on October 15, 2022.

5. Restricted Stock Unit represents a contingent right to receive one share of issuer common stock subject to continued employment.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Mark D. Austin, by Power of Attorney	10/14/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.